|Description||N6-[2-(4-Aminophenyl)ethyl]adenosine is a potent, non-selective adenosine A3 adenosine receptor agonist. It could enhance the protective activity of carbamazepine and the protective activity potentiates most likely through the A subtype of adenosine receptors at low doses. It also enhances the anticonvulsive effect of other antiepileptics via adenosine A1 receptors at higher doses. It has no significant effect on seizure parameters in amygdala-kindled rats in vivo. It is combined with antiepileptic drugs administered at doses ineffective in fully kindled rats.|
|Solubility||10 mM in DMSO|
|Application||N6-[2-(4-Aminophenyl)ethyl]adenosine could enhance the protective activity of carbamazepine. It also enhances the anticonvulsive effect of other antiepileptic.|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Boiling Point||781.8±70.0 °C | Condition: Press: 760 Torr|
|Density||1.65±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr|
CVT5440 is a selective, high affinity A(2B) adenosine receptor antagonist. It may has the potential treatment of asthma and has good selectivity.
CGS 21680 Hydrochloride
CGS 21680 Hcl is an adenosine A2 receptor agonist with IC50 of 22 nM, exhibits 140-fold over A1 receptor.
412348 is an adenosine A2A receptor antagonist with anti-Parkinsonian activity in both rodent andprimate animal models. Because of its high affinity for the ade...
KF21213 is a highly selective ligand for mapping CNS adenosine A2A receptors. The Ki values of KF21213 were 3.0 nM for the adenosine A2A receptors and >10,000 n...
Ticlopidine HCl is an P2 receptor inhibitor against ADP-induced platelet aggregation with IC50 of ~2 μM.
Dyphylline is a xanthine derivative with bronchodilator and vasodilator effects.It is used in the treatment of respiratory disorders like asthma, cardiac dyspne...
Regadenoson, as a coronary vasodilator it is a selective A2A adenosine receptor agonist in myocardial imaging.
N-0861 racemate is the racemate of N-0861 which appears to be an effective and selective A1 adenosine receptor antagonist in humans.
UP202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression.
LUF6000 is an allosteric modulator of the human A3 adenosine receptor (AR). It was found to be an allosteric enhancer of Emax. It exerted an Emax-enhancing effe...
N6-[2-(4-Aminophenyl)ethyl]adenosine is a potent, non-selective adenosine A3 adenosine receptor agonist. It could enhance the protective activity of carbamazepi...
An orally administered, potent and selective inhibitor of the adenosine 2a (A2a) receptor
GP531 is a novel riboside with similar structural and anti-ischemic properties to the adenosine-regulating agent (ARA) acadesine.
N-[(4-Aminophenyl)methyl]adenosine is a adenosine receptor inhibitor with Ki value of 29 nM for Rat ecto-5′-Nucleotidase.
Preladenant is a potent as Adenosine A2 receptor antagonists.
CPI-444 is a potent, orally available, selective antagonist of the adenosine A2A receptor that has been well tolerated in Ph 1/1b studies in non-oncology indica...
Potent, highly irreversible selective A2A antagonist
GR 79236, an effective Adenosine A1 receptor agonist, could probably be used as an anti-inflammatory agent. IC50: 3.1 nM(Ki).
Capadenoson is a potent and selective adenosine A1 receptor agonist, which is a powerful protective mechanism in cerebral.
FR-194921 is a potent, selective and orally active antagonist for central adenosine A1 receptors that displays high affinity and selectivity for the adenosine A...